ÂÜÀòÂÒÂ×

Madhusudan Natarajan has two decades of experience in human pharmaceutical development (Pfizer, Shire/Takeda), startups (Physiome Sciences), and academic research (Asst. Professor, University of Texas Southwestern Medical Center in Dallas) studying basic biological questions underpinning biology in multiple diseases and development of therapeutic approaches to address them. He is also Head of the Rare Diseases Drug Discovery Unit at Takeda.

Madhusudan received his Ph.D. in Neurobiology from Northwestern University, USA.